Heart failure (HF) with preserved ejection fraction (HFpEF) is an emerging problem of cardiovascular medicine with increasing prevalence and poor prognosis [1,2]. The pathophysiological mechanisms of HFpEF are still poorly understood. Leukocytes play important role in the pathogenesis and prognosis of HF with reduced ejection fraction (HFrEF) via their contribution to inflammation, extracellular matrix remodelling, and reparatory processes [3]. Relative lymphopenia is a strong predictor of mortality in severe HFrEF [4,5]. In contrast, neutrophils are often increased in HFrEF and pose an increased risk of all-cause and cardiovascular mortality [6]. However, only scarce data are available on the impact of leukocytes on pathophysiology and outcome in HFpEF. In this study we aimed to compare levels of neutrophiles, lymphocytes and monocytes between patients with HFrEF and HFpEF and to establish their impact on the mortality in HFpEF. The total number of 1019 HF patients referred the Cardiology Clinic of the Grodno Regional Clinical Hospital in 2008–2009 with either HFpEF (n=856, age 55[49–64], 81% males) or HFrEF (n=163, age 58[51–65], 56% males) were included into the study. The diagnosis of HFrEF or HFpEF was established according to the current ESC guidelines [7]. Patients with life expectancy b1 year due to noncardiac courses (e.g., cancer) and those with terminal HF (NYHA class IV) were not included. All subjects underwent transthoracic echocardiography with LVEF measured using the modified Simpson's biplane method and diastolic function assessed by evaluating E/A ratio. The leucocytes were measured using an automatic haematocytometer (Micros-60 Horiba, ABX Diagnostics, France). The patients were followed for at least 1 year with median (interquartile range) follow-up duration of 17[14–20]months with the end-point of any-cause death registered. The study was approved by the Institutional Research Board of the Grodno State Medical University. The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology [8]. Most patients had mild HF (NYHA I–II class in 98% of HFpEF, 82% of HFrEF) predominantly of ischemic aetiology (74% of HFpEF, 73% of HFrEF). Patients with HFrEF had lower body mass index (p=0.017), and proportion of patients with history of hypertension (pb0.001), higher proportions of males (pb0.001), and subjects with history of previous myocardial infarction (p=0.002). PatientswithHFpEF as comparedwithHFrEF had significantly lower neutrophil count (4140[3498–5293] vs. 3933[3247–4760] per μl, p=0.004) and percentage (63[58–68]% vs. 65[59–69]%, p=0.018) and higher lymphocyte percentage (30[26–34]% vs. 29[24–33], p=0.004). On regression analysis, significant clinical predictors of reduced LVEF in the whole study population were advanced age, male sex, history of hypertension and atrial fibrillation (pb0.05). Among leukocytes, high neutrophil count and percentage and low lymphocyte percentage were associated with reduced LVEF and remained so after adjustment for the clinical predictors above (pb0.05). During the follow-up period, 41 deaths (4.02%) occurred (28 in HFpEF and 13 in HFrEF). Using logistic regression analysis, a history of hypertension was the only significant clinical predictor of death in HFpEF. Among leukocytes, high monocyte count was predictive of death in HFpEF before (p=0.01) and after (p=0.012) adjustment for age, LVEF, and hypertension (p=0.012) (Table 1). In HFpEF 0167-5273/$ – see front matter © 2011 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.ijcard.2011.12.049
Read full abstract